- Issuer ticker
-
ELTP
- Reported as of
-
28 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
3
- Accepted by SEC
-
06 Nov 2026, 16:36:42 UTC
Reporting owner
1 detail
- Reporting owner signature
-
John W LaRocca
Filing notes and source
Key filing fact
John W. LaRocca filed Form 3 for ELITE PHARMACEUTICALS INC /NV/ (ELTP) on 06 Nov 2026.
Key facts
- This page summarizes John W. LaRocca's Form 3 filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Nov 2026, 16:36.
Change
- Previous filing in this sequence was filed on 18 Sep 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0001732197
Primary reporting owner
LaRocca John
- Relationship
-
Director
- Address
- C/O ELITE PHARMACEUTICALS, INC., 165 LUDLOW AVENUE, NORTHVALE
- Signature
- John W LaRocca
- Signature date
- 06 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 88,534
- Date
- 28 Oct 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.